ALAB vs AVGO: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
AVGO is the larger of the two ($1.56T market cap): the incumbent the market prices for continued execution (16.75x forward earnings, beta 1.51). ALAB is the smaller challenger ($37.41B), actually pricier on forward earnings (30.15x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
ALAB vs AVGO: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | ALAB | AVGO | What it tells you |
|---|---|---|---|
| Market cap | $37.41B | $1.56T | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 30.15 | 16.75 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 84.59 | 41.65 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 3.86 | 1.51 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 29% of range | 18% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 18.71 | 15.62 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: AVGO is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how ALAB and AVGO affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ALAB and AVGO share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ALAB and AVGO exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Astera Labs (ALAB) do?
Astera Labs makes purpose-built connectivity hardware and software for AI and cloud infrastructure. Its core products are Aries PCIe and CXL smart DSP retimers (which preserve signal integrity so data can travel farther and faster inside a server), Taurus Ethernet smart cable modules (for high-speed 400G and 800G links between racks), Leo CXL memory controllers (which enable memory expansion and pooling), and the newer Scorpio fabric switches (P-Series PCIe switches and the X-Series AI fabric switch for connecting large GPU clusters). The company makes money by selling these chips and modules to hyperscalers, AI accelerator vendors, and system builders, and pairs them with a software layer for diagnostics and fleet management, positioning itself as a connectivity platform rather than a single-chip supplier.
What does Broadcom (AVGO) do?
Broadcom is one of the largest semiconductor companies in the world, plus a major enterprise software business after acquiring VMware in 2023. The semiconductor business has two main pieces. Networking and wireless silicon (Ethernet switches, optical components, custom ASICs for hyperscalers) is critical to AI data centers. Custom silicon (XPUs) for hyperscaler AI accelerators is a major growth driver: Broadcom designs custom AI chips for customers like Google (TPU), Meta (MTIA), and others.
ALAB vs AVGO: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- ALAB drivers: Rising connectivity content per AI cluster; The Scorpio fabric switch ramp.
- AVGO drivers: Custom AI accelerators (XPUs) for hyperscalers; AI networking silicon.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Customer concentration is significant, with a large share of revenue tied to a handful of hyperscalers and AI accelerator vendors, so the loss or slowdown of one large customer would be material. For AVGO, customer concentration in custom AI silicon (top customers are Google, Meta, and reportedly OpenAI): a pause or redesign at one hyperscaler would show up quickly in revenue.
ALAB or AVGO: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ALAB if you believe its drivers more; AVGO if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ALAB and AVGO guides.
ALAB vs AVGO: the full fundamentals
ALAB. Astera Labs still trades at a steep premium on both sales and earnings, but less steep than in June: the multiple on trailing sales has fallen from ~65x to ~42x as revenue doubled and the share price came off its high. The valuation depends on continued hyperscaler capex and successful product ramps like Scorpio; consensus expects 2026 revenue near $1.91 billion and 2027 near $2.98 billion. The November 3, 2026 report, with consensus at ~$551 million of revenue, is the next test of that path.
AVGO. Broadcom's valuation reflects dominant networking semiconductor positions, fast-growing custom AI silicon revenue, and high-margin enterprise software from VMware. At about 44x trailing GAAP earnings but only about 17x forward estimates, the multiple assumes the steep growth analysts project (consensus EPS of about $19.40 for fiscal 2027) actually arrives. Analysts rate the stock a strong buy with an average target near $528, well above the mid-October price of about $335.
Headline figures (approximate, October 2026): ALAB shows revenue (ttm) ~$1.2 billion (FY2025 was ~$852 million), revenue growth (q2 2026 yoy) ~105% (Q1 2026 was ~93%), q2 2026 eps $0.80 non-GAAP vs $0.69 expected; GAAP net income ~$153 million, margins (ttm) ~75% gross, ~23% operating, ~31% net; AVGO shows revenue (ttm) ~$89.1 billion (combined semis and software); latest quarter up ~85% YoY, operating margin ~54% (gross margin ~76%), net income (ttm) ~$38.3 billion, eps ~$7.59 GAAP (TTM); latest quarter adjusted $3.32 vs ~$3.24 consensus.
The bottom line: ALAB vs AVGO
ALAB and AVGO are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ALAB and AVGO exposure against your real portfolio. It is not an investment adviser.
Wondering how ALAB or AVGO fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Astera Labs
Ask Walnut's AI anything about ALAB and see how it fits what you own.
FAQ
What is the difference between ALAB and AVGO?
+
Astera Labs makes purpose-built connectivity hardware and software for AI and cloud infrastructure. Broadcom is one of the largest semiconductor companies in the world, plus a major enterprise software business after acquiring VMware in 2023. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is ALAB or AVGO the better stock?
+
Neither is universally better. AVGO is the larger incumbent; ALAB is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, ALAB or AVGO?
+
On forward P/E (as of November 2026), ALAB trades at 30.15x and AVGO at 16.75x, so AVGO is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both ALAB and AVGO?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of ALAB vs AVGO?
+
ALAB: Customer concentration is significant, with a large share of revenue tied to a handful of hyperscalers and AI accelerator vendors, so the loss or slowdown of one large customer would be material. Broadcom and Marvell are far larger and better-capitalized competitors in connectivity and custom silicon, and both can bundle or undercut on price. Demand is tied to AI data center capex, which is cyclical and could slow or pause. The stock also carries a premium valuation that prices in years of continued rapid growth, leaving little margin for execution stumbles. The 2026 trading range shows how quickly sentiment can move: the stock has swung between ~$98 and ~$499 over 52 weeks and sits ~42% below the high. Insider selling has continued (one filing in October 2026 showed ~$4.7 million of shares sold), and the comparison set has widened to include Credo and optical suppliers as connectivity moves toward optics. AVGO: Customer concentration in custom AI silicon (top customers are Google, Meta, and reportedly OpenAI): a pause or redesign at one hyperscaler would show up quickly in revenue. Hyperscaler AI spending depends on financing, and in October 2026 Hock Tan himself said capital may be the biggest constraint on AI expansion; higher bond yields and doubts about AI returns drove a semiconductor sell-off that left AVGO about 32% below its 52-week high. Forward estimates assume fiscal 2027 revenue growth of roughly 66%, so any shortfall against those expectations could hit the stock. VMware integration creates customer pushback and potential churn in the enterprise software business, and the company carries about $59 billion of debt.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ALAB or AVGO; figures are approximate and dated (as of November 2026). Verify current data before investing.